on 08 Aug 2023
Last Applicant/ Owned by
Teslova 3
Plzen
CZ
30100
Serial Number
88073859 filed on 10th Aug 2018
Registration Number
7133412 registered on 08th Aug 2023
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Scientific and technological services and research projects for the preparation of peptide and antibody libraries, namely, chemical analysis; scientific and technological services and research projects for the identification and characterisation of binding molecules, namely, in the field of antibody discovery, antibody research and antibody optimization in the nature of working on and evaluation o Read More
Scientific and technological services and research projects for the preparation of peptide and antibody libraries, namely, chemical analysis; scientific and technological services and research projects for the identification and characterisation of binding molecules, namely, in the field of antibody discovery, antibody research and antibody optimization in the nature of working on and evaluation of chemical analyses; scientific and technological services and research projects for the preparation, identification and characterisation of peptides and antibodies, namely, medical research in the field of antibody discovery, antibody research and antibody optimization; scientific and technological services and research projects for the preparation and identification of recombinant antibodies, single-chain antibodies, diabodies, tandabs, flexibodies, triabodies, tetrabodies, bivalent antibodies, multivalent antibodies, whole immunoglobulins, and antibody fragments, in particular Fab and scFv fragments, and of nucleic acid sequences coding for these molecules, namely, in the field of antibody discovery, antibody research and antibody optimization, namely, scientific research in the field of antibodies; scientific and technological services and research projects in relation to antibody discovery, namely, medical research in the field of antibody research and drug design; scientific and technological services and research projects in relation to screening of natural, engineered and immunized libraries, namely, medical research in the field of antibody discovery for scientific research services; scientific and technological services and research projects in relation to screening of antibody libraries, namely, in the field of antibody discovery for scientific research services; scientific and technological services and research projects in relation to phage display, phage panning and yeast display vectors, namely, in the field of antibody discovery in the nature of chemical analysis; scientific and technological services and research projects in relation to next-generation yeast display and antibody selection process, namely, in the field of antibody discovery in the nature of chemical analysis; scientific and technological services and research projects in relation to the upstream enrichment of target-specific candidates and batch cloning into yeast-display vectors in the nature of research and development services in the field of antibodies; scientific and technological services in relation to drug discovery by high throughput screen and antibody delivery for therapeutic application, namely, scientific research in the field of antibody research and drug design; scientific and technological services and research projects in relation to batch-cloning and screening of natural, engineered and immunized libraries, namely, scientific research in the field of antibodies and antibody optimization; scientific and technological services and research projects in relation to batch-cloning and screening of antibody libraries, namely, scientific research in the field of antibodies and antibody optimization; scientific and technological services and research projects in relation to antibody development strategies, namely, scientific research in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to the optimization, maturation and humanization of antibody drug candidates, namely, in the field of antibody research and drug design; scientific and technological services and research projects in relation to multi-factor antibody optimization, namely, scientific research in the field of antibody research and drug design; scientific and technological services and research projects in relation to the optimization of antibody binding affinity, antibody stability, species cross-reactivity, specificity, developability, producibility, and human properties, namely, scientific research in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to human and non-human lead antibody technology, namely, scientific research in the field of antibody research and antibody optimization
27th Sep 2021
27th Sep 2021
No 88073859
No Service Mark
No 50125-T89001
No
No
No
No
No
No
No
No
26.01.21 -
Circles that are totally or partially shaded
26.01.31 -
Five or more circles
26.11.09 -
Rectangles made of geometric figures, objects, humans, plants or animals
Status Date | Action Taken |
---|---|
08th Aug 2023 | REGISTERED-PRINCIPAL REGISTER |
08th Aug 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
06th Jul 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
05th Jul 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
09th Jun 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
08th Jun 2023 | SOU EXTENSION 5 GRANTED |
08th Jun 2023 | STATEMENT OF USE PROCESSING COMPLETE |
30th May 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
24th May 2023 | TEAS STATEMENT OF USE RECEIVED |
24th May 2023 | TEAS EXTENSION RECEIVED |